Immix Biopharma

Developer of therapeutics for amyloidosis, autoimmune diseases, and oncology indications

placeLos Angeles, California, United States calendar_todayFounded 2012 groups11 employees language immixbio.com

Registered entities

Innovation

7 patent families (3 granted) — focus: Human necessities; filing pace accelerating. Cited 87 times.

YearFilings
20173
20182
20191
20202
20233
20244

Social engagement

Social engagement: 8.7K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital2100%

Recent activity

27 May 2026
Event
Jefferies Global Healthcare Conference
26 May 2026
Leadership hire
Chief Medical Officer
Coming soon